Taxiarchis Kourelis
@Taxkourel
Followers
900
Following
4K
Statuses
3K
Trying to be a good husband, father and doctor as much as I can. Hate all things Congophilic.Tweets are my own.
Joined August 2015
@Dr_Murad_Ali @drsanjeev1980 @VincentRK @MayoAmyloid @Amyloidosis_ARC @MorieGertz @myelomaMD @ADispenzieri Trying to clarify that with ARC but likely no. They specifically mention the candidates need to be licensed to practice in the US and intent to practice in the US after completion of their fellowship.
0
0
1
Now accepting applications for the #Amyloidosis Fellowship @MayoAmyloid. Supported by @Amyloidosis_ARC , with the goal of training expert clinicians while fostering opportunities for clinical and translational research. For more information and to apply
0
0
2
RT @SWOG: Now enrolling: @SWOG S2213 phase 3 study in patients newly diagnosed with AL #amyloidosis. Compares #stemcelltransplant to consol…
0
5
0
RT @End_myeloma: International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of mu…
0
39
0
No surprises here based on clinical experience. Nice paper!
🎉Finally published🎉 Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma @Hemasphere_EHA #mmsm
0
1
6
@AaronGoodman33 And I am no AI expert and also mean no offense but many of the responses to this thread do not seem compatible with the rate of advancement in AI. I feel it is like someone seeing the Wright brothers and saying airplanes will never be used for transportation…
0
0
4
RT @Myeloma_Doc: #Myeloma Paper of the Day: Long-term follow-up of Phase 3 GMMG ReLApsE trial of second ASCT finds median PFS was 20.5 & 19…
0
18
0
@bdermanmd Treatment related mortality is tough to digest even with suboptimal ID prophy. If RCT I could b more convinced. Maybe for horrible EMD cases where one is willing to risk more? I think other partners may be better for bites (cell mods? Or something with less infectious risk).
0
0
0
@RahulBanerjeeMD @JoshuaRichterMD @GKaurMD @andrew02114 @OmarNadeemMD @DrOlaLandgren @JKaufmanMD @DrKrinaPatel Agree. Even in some robust elderly patients i would do quads (especially if HR disease) but would do a “scale up” approach (drd add V if doing great) rather than use from the get go.
1
1
4
Fibrosis/matrix/metabolism stuff seemed (to me) "generic" for HFpEF but the complement seemed interesting and unique to advanced amyloid but not sure if chicken or egg :-) @MayoAmyloid @MorieGertz @ADispenzieri @MarthaGrogan1
0
0
4
I always find it disappointing that sometimes we (clinicians) would rather keep giving treatments that know will not work as opposed to having a tough, but honest, discussion with the patient and family about end of life planning. At least do both but don’t treat it as a taboo
1
2
12
@Jmarksloan Although I value my work immensely consider this: if any one of us no matter how “important “ in the work place dropped dead tomorrow, it would be business as usual come Monday at work plus perhaps a nice speech or something. At home with your loved ones you are irreplaceable.
0
0
6